
Middle East and Africa Intracranial Aneurysm Market Report and Forecast 2024-2032
Description
Middle East and Africa Intracranial Aneurysm Market Report and Forecast 2024-2032
Middle East and Africa Intracranial Aneurysm Market Report and Forecast 2024-2032
Middle East and Africa Intracranial Aneurysm Market Size
The global intracranial aneurysm market was valued at USD 1.2 billion in 2023, with the Middle East and Africa holding a significant market share. The market is driven by the growing demand for minimally invasive treatment options. It is expected to grow at a CAGR of 8.8% during the forecast period of 2024-2032, with the values likely to attain USD 2.6 billion by 2032.
Middle East and Africa Intracranial Aneurysm Market Outlook
- A ruptured intracranial aneurysm can be life-threatening, supported by recent data that reveals around 10% of brain aneurysms rupture each year, with about 20% of the individuals dying before hospitalization and nearly 30% dying within a span of 3 months.
- The Middle East and Africa intracranial aneurysm market share is influenced by the rise in clinical data registries for post-marketing surveillance of medical devices used for endovascular aneurysm care. For instance, INSPIRE-A is an international registry sponsored by Medtronic plc, engaged in the assessment of flow-diverter imaging results.
- One of the major market trends is the rising preference for minimally invasive procedures associated with reduced complications, shorter recovery times, and improved patient outcomes.
Intracranial aneurysms or brain aneurysms are a weakened or bulging area in the wall of a blood vessel in the brain. High blood pressure, smoking, and a family history of aneurysms are some of the risk factors for developing this balloon-like sac filled with blood. Surgical clipping, endovascular coiling, and flow diversion are some treatment options used to prevent rupture or re-rupture of the aneurysm. The growing demand for less invasive procedures associated with reduced complications, shorter recovery times, and improved patient outcomes significantly contributes to the Middle East and Africa intracranial aneurysm market growth.
When an aneurysm ruptures, it can cause bleeding into the space around the brain (subarachnoid hemorrhage), which can be life-threatening and often leads to a stroke and brain damage. Recent data reveals that around 10% of brain aneurysms rupture each year, with about 20% of the individuals dying before hospitalization and nearly 30% dying within a span of 3 months. In Africa, intracranial aneurysms pose a serious health challenge, where disparities in healthcare provision and limited resources act as a constraint to disease management. This also indicates the need for effective treatment alternatives and diagnostic techniques in healthcare facilities to successfully manage the condition. With the growing emphasis on improving healthcare infrastructure and rising preference for procedures with minimal postoperative risks, the Middle East and Africa intracranial aneurysm market demand is expected to witness a surge in the forecast period.
The market share is influenced by the rise in clinical data registries for post-marketing surveillance to evaluate the safety and efficacy of medical devices. For instance, INSPIRE-A is an international registry sponsored by Medtronic plc, engaged in the assessment of flow-diverter imaging results, boasting over 1,400 participants enrolled from more than 40 sites including South Africa, and the United Arab Emirates (UAE). This high-volume global study monitors and analyzes outcomes in intracranial aneurysm patients treated with Medtronic neurovascular medical devices such as Flex, Shield, and Vantage flow diverters. The findings from such registries are crucial to advancing endovascular aneurysm care in the region. Additionally, these studies have the potential to inform device development and stimulate innovation in product design, which is likely to elevate the market value.
Middle East and Africa Intracranial Aneurysm Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Treatment Type
- Endovascular Coiling
- Surgical Clipping
- Flow Diverters
- Other Treatment Types
- Hospitals
- Clinics
- Others
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Stryker
- B. Braun Melsungen AG
- Medtronic
- Terumo Corporation
- MicroPort Scientific Corporation
- Raumedic AG
- Johnson & Johnson
- Codman Neuro (Integra Lifesciences)
- Microvention Inc.
- Integra Lifesciences Corporation
FAQs
- What is the Middle East and Africa intracranial aneurysm market forecast outlook for 2024-2032?
- What are the major factors aiding the Middle East and Africa intracranial aneurysm market demand?
- What are the major Middle East and Africa intracranial aneurysm market trends?
- What is the market segmentation based on the type?
- What is the major end use of the intracranial aneurysm?
- What is the market segmentation by countries?
- Who are the key players involved in the Middle East and Africa intracranial aneurysm market?
Meta description
The Middle East and Africa intracranial aneurysm market is poised for growth, driven by the expansion of the global market, which was valued at USD 1.2 billion in 2023 and is projected to grow at a CAGR of 8.8% during the forecast period of 2024-2032.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Middle East and Africa Intracranial Aneurysm Market Overview
- 3.1 Middle East and Africa Intracranial Aneurysm Market Historical Value (2017-2023)
- 3.2 Middle East and Africa Intracranial Aneurysm Market Forecast Value (2024-2032)
- 4 Middle East and Africa Intracranial Aneurysm Market Landscape*
- 4.1 Middle East and Africa Intracranial Aneurysm: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Middle East and Africa Intracranial Aneurysm: Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 5 Middle East and Africa Intracranial Aneurysm Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Analysis
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Middle East and Africa Intracranial Aneurysm Market Segmentation (2017-2032)
- 6.1 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by Type
- 6.1.1 Market Overview
- 6.1.2 Surgical Clipping
- 6.1.3 Endovascular Coiling
- 6.1.4 Flow Diverters
- 6.1.5 Others
- 6.2 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by End-Use
- 6.2.1 Market Overview
- 6.2.2 Hospitals
- 6.2.3 Clinics
- 6.2.4 Others
- 6.3 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by Countries
- 6.3.1 Market Overview
- 6.3.2 Saudi Arabia
- 6.3.3 United Arab Emirates
- 6.3.4 Nigeria
- 6.3.5 South Africa
- 6.3.6 Others
- 7 Saudi Arabia Intracranial Aneurysm Market (2017-2032)
- 7.1 Saudi Arabia Intracranial Aneurysm Market (2017-2032) by Type
- 7.1.1 Market Overview
- 7.1.2 Surgical Clipping
- 7.1.3 Endovascular Coiling
- 7.1.4 Flow Diverters
- 7.1.5 Others
- 7.2 Saudi Arabia Intracranial Aneurysm Market (2017-2032) by End-Use
- 7.2.1 Market Overview
- 7.2.2 Hospitals
- 7.2.3 Clinics
- 7.2.4 Others
- 8 United Arab Emirates Intracranial Aneurysm Market (2017-2032)
- 8.1 United Arab Emirates Intracranial Aneurysm Market (2017-2032) by Type
- 8.1.1 Market Overview
- 8.1.2 Surgical Clipping
- 8.1.3 Endovascular Coiling
- 8.1.4 Flow Diverters
- 8.1.5 Others
- 8.2 United Arab Emirates Intracranial Aneurysm Market (2017-2032) by End-Use
- 8.2.1 Market Overview
- 8.2.2 Hospitals
- 8.2.3 Clinics
- 8.2.4 Others
- 9 Nigeria Intracranial Aneurysm Market (2017-2032)
- 9.1 Nigeria Intracranial Aneurysm Market (2017-2032) by Type
- 9.1.1 Market Overview
- 9.1.2 Surgical Clipping
- 9.1.3 Endovascular Coiling
- 9.1.4 Flow Diverters
- 9.1.5 Others
- 9.2 Nigeria Intracranial Aneurysm Market (2017-2032) by End-Use
- 9.2.1 Market Overview
- 9.2.2 Hospitals
- 9.2.3 Clinics
- 9.2.4 Others
- 10 South Africa Intracranial Aneurysm Market (2017-2032)
- 10.1 South Africa Intracranial Aneurysm Market (2017-2032) by Type
- 10.1.1 Market Overview
- 10.1.2 Surgical Clipping
- 10.1.3 Endovascular Coiling
- 10.1.4 Flow Diverters
- 10.1.5 Others
- 10.2 South Africa Intracranial Aneurysm Market (2017-2032) by End-Use
- 10.2.1 Market Overview
- 10.2.2 Hospitals
- 10.2.3 Clinics
- 10.2.4 Others
- 11 Regulatory Framework
- 12 Funding and Investment Analysis
- 12.1 Analysis by Funding Instances
- 12.2 Analysis by Type of Funding
- 12.3 Analysis by Funding Amount
- 12.4 Analysis by Leading Players
- 12.5 Analysis by Leading Investors
- 12.6 Analysis by Geography
- 13 Partnership and Collaborations Analysis
- 13.1 Analysis by Partnership Instances
- 13.2 Analysis by Type of Partnership
- 13.3 Analysis by Leading Players
- 13.4 Analysis by Geography
- 14 Supplier Landscape
- 14.1 Market Share by Top 5 Companies
- 14.2 Stryker
- 14.2.1 Financial Analysis
- 14.2.2 Product Portfolio
- 14.2.3 Demographic Reach and Achievements
- 14.2.4 Mergers and Acquisitions
- 14.2.5 Certifications
- 14.3 B. Braun Melsungen AG
- 14.3.1 Financial Analysis
- 14.3.2 Product Portfolio
- 14.3.3 Demographic Reach and Achievements
- 14.3.4 Mergers and Acquisitions
- 14.3.5 Certifications
- 14.4 Medtronic
- 14.4.1 Financial Analysis
- 14.4.2 Product Portfolio
- 14.4.3 Demographic Reach and Achievements
- 14.4.4 Mergers and Acquisitions
- 14.4.5 Certifications
- 14.5 Terumo Corporation
- 14.5.1 Financial Analysis
- 14.5.2 Product Portfolio
- 14.5.3 Demographic Reach and Achievements
- 14.5.4 Mergers and Acquisitions
- 14.5.5 Certifications
- 14.6 MicroPort Scientific Corporation
- 14.6.1 Financial Analysis
- 14.6.2 Product Portfolio
- 14.6.3 Demographic Reach and Achievements
- 14.6.4 Mergers and Acquisitions
- 14.6.5 Certifications
- 14.7 Raumedic AG
- 14.7.1 Financial Analysis
- 14.7.2 Product Portfolio
- 14.7.3 Demographic Reach and Achievements
- 14.7.4 Mergers and Acquisitions
- 14.7.5 Certifications
- 14.8 Johnson & Johnson
- 14.8.1 Financial Analysis
- 14.8.2 Product Portfolio
- 14.8.3 Demographic Reach and Achievements
- 14.8.4 Mergers and Acquisitions
- 14.8.5 Certification
- 14.9 Codman Neuro (Integra Lifesciences)
- 14.9.1 Financial Analysis
- 14.9.2 Product Portfolio
- 14.9.3 Demographic Reach and Achievements
- 14.9.4 Mergers and Acquisitions
- 14.9.5 Certifications
- 14.10 Microvention Inc.
- 14.10.1 Financial Analysis
- 14.10.2 Product Portfolio
- 14.10.3 Demographic Reach and Achievements
- 14.10.4 Mergers and Acquisitions
- 14.10.5 Certifications
- 14.11 Integra Lifesciences Corporation
- 14.11.1 Financial Analysis
- 14.11.2 Product Portfolio
- 14.11.3 Demographic Reach and Achievements
- 14.11.4 Mergers and Acquisitions
- 14.11.5 Certifications
- 15 Middle East and Africa Intracranial Aneurysm Market – Distribution Model (Additional Insight)
- 15.1 Overview
- 15.2 Potential Distributors
- 15.3 Key Parameters for Distribution Partner Assessment
- 16 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 17 Company Competitiveness Analysis (Additional Insight)
- 17.1 Very Small Companies
- 17.2 Small Companies
- 17.3 Mid-Sized Companies
- 17.4 Large Companies
- 17.5 Very Large Companies
- 18 Payment Methods (Additional Insight)
- 18.1 Government Funded
- 18.2 Private Insurance
- 18.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.